IndraLab

Statements

USP9X inhibits cisplatin. 2 / 2

| 2

➶

reach

"However, USP9X knockdown increased NSCLC cell sensitivity to cisplatin, as it did with WP1130."

28446729

➶

reach

"Knockdown of USP9X reverses cisplatin resistance by decreasing beta-catenin expression in nasopharyngeal carcinoma cells."

34097426

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP9X inhibits cisplatin. 2 / 2

INDRA sources:

Databases

Reading